Statements and Voting Guidance from Major Investors May Offer Companies a Roadmap For What Lies Ahead
Submitted by Boston Scientific
Intense focus on the environmental prong of ESG is being driven by a constellation of private actors. Institutional investors, in particular, are making their voices heard through the 2022 proxy season by urging companies to demonstrate meaningful progress on climate and environmental sustainability. And in fact, many companies are already doing so in an effort to distinguish themselves in the competition for customers, talent and investor funds.
Beyond simply complying with changing regulatory minimum standards, making ESG a priority should include watching for signals from institutional investors, proxy advisors and other advocacy groups.
Every business will have its own focus with respect to environmental practices. But in general, the following approaches can help your organization maintain a positive relationship with investors while progressing toward your goals:
Continue reading here
Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties.
About Boston Scientific
Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for 40 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. For more information, visit www.bostonscientific.com and connect on Twitter and Facebook.
More from Boston Scientific